Alex Pharma’s OGM endorses EGP 12.2/share dividends payment
Updated 10/16/2022 10:48:22 AM
Arab Finance: The ordinary general meeting (OGM) of Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) endorsed the payment of cash dividends of EGP 12.20 per share to shareholders for fiscal year (FY) 2021/2022, according to a statement published on October 16th.
It is worth noting that the company previously announced it posted a 3.83% year-on-year (YoY) increase in net profit after tax fiscal year (FY) 2021/2022, recording EGP 121.479 million, compared to a profit of EGP 116.996 million in FY 2020/2021.
Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.
